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Abstract. Kinetic competition experiments have dem- 
onstrated that at least some factors required for the nu- 
clear import of proteins and U snRNPs are distinct. 
Both import processes require energy, and in the case 
of protein import, the energy requirement is known to 
be at least partly met by GTP hydrolysis by the Ran 
GTPase. We have compared the effects of nonhydro- 
lyzable GTP analogues and two mutant Ran proteins 
on the nuclear import of proteins and U snRNPs in 
vitro. The mutant Ran proteins have different defects; 
Q69L (glutamine 69 changed to leucine) is defective in 
GTP hydrolysis while T24N (threonine 24 changed to 
asparagine) is defective in binding GTP. Both protein 
and snRNP import are sensitive either to the presence 
of the two mutant Ran proteins, which act as dominant 
negative inhibitors of nuclear import, or to incubation 
with nonhydrolyzable GTP analogues. This demon- 
strates that there is a requirement for a GTPase activity 
for the import of U snRNPs, as well as proteins, into 
the nucleus. The dominant negative effects of the two 
mutant Ran proteins indicate that the pathways of pro- 
tein and snRNP import share at least one common 
component. 
T 
~E study of macromolecular import into the nucleus 
has  concentrated  on  the  transport  of karyophilic 
proteins, whose uptake is generally mediated by a 
nuclear  localization  signal  (NLS) 1  in  the  primary  se- 
quence. This uptake is a two step process, the first step is 
energy independent docking of the karyophile at the outer 
face of the nuclear envelope in the vicinity of nuclear pore 
complexes (NPCs). The second step is energy dependent 
translocation of the karyophile through the NPC (New- 
meyer and Forbes, 1988; Richardson et al.,  1988; for re- 
views see  Powers and Forbes,  1994; Sweet and  Gerace, 
1995; Melchior and Gerace, 1995). 
The development of a permeabilized-cell in vitro system 
that accurately recapitulates nuclear protein import (Adam 
et al., 1990) has permitted the fractionation of activities es- 
sential for either docking or the complete import reaction 
(Moore and Blobel, 1992). Further fractionation led to the 
subsequent purification and characterization of four solu- 
ble components essential for nuclear import. Two of these 
are part of a heterodimeric complex that binds, in the cyto- 
plasm,  to  NLS-containing proteins  and  mediates  their 
docking to NPCs (see below). This complex thus corre- 
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sponds to the original definition of an NLS receptor. Al- 
though there currently is a number of alternative nomen- 
clatures for the two subunits (see below), we will use the 
term  NLS receptor  to mean any of the functional het- 
erodimeric complexes. 
The smaller NLS receptor subunit has been character- 
ized in various organisms. While in yeast it appears that 
there is a single protein called Srplp (Yano et al., 1992) in 
each of the vertebrate species, a family of genes encode re- 
lated, but quite diverse, proteins. These have been charac- 
terized from bovine, Xenopus, mouse, human, and Dro- 
sophila  sources  and  called  NLS  receptor,  (Adam  and 
Adam, 1994),  importin a  (or  60)  (G6rlich et al.,  1994), 
hSRP1 (Cortes et al., 1994), Rchl/hSRPla (Cuomo et al., 
1994; Weis et al.,  1995), Karyopherin ct (Moroianu et al., 
1995a), m-importin (Imamoto et al., 1995a), and Pendulin/ 
OHO31  (Kussel  and Frasch,  1995; T6r6k  et  al.,  1995). 
There  is  general  agreement  that  it  is  this  subunit  that 
makes  the  critical  binding  interaction  with  the  NLS. 
Whether the individual members of the vertebrate fami- 
lies are functionally different remains to be tested. In con- 
trast, the larger of the two receptor subunits appears to be 
a single protein in each species. Again, homologues from 
various  species  including human, Xenopus,  mouse,  and 
yeast have been characterized (Chi et al., 1995; Enenkel et 
al., 1995; G6rlich et al., 1995a; Imamoto et al., 1995b; Radu 
et al.,  1995)  and named p97,  importin 13, karyopherin 13, 
PTAC97, etc. This subunit functions to target the complex 
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NLS-containing protein to the NPC (Chi et al., 1995; G6r- 
lich et al., 1995a,b; Imamoto et al., 1995b; Moroianu et al., 
1995b;  Radu et al.,  1995); and direct interaction between 
this  subunit  and  nucleoporins has  been reported (Mor- 
oianu et  al.,  1995b;  Radu  et al.,  1995).  Interestingly, in 
complete import assays, the small subunit of the receptor 
has been shown to enter the nucleoplasm with the NLS- 
containing  protein  while  the  large  subunit  apparently 
translocates through the pore, and is found in association 
with the inner face of the NPC but not in the nucleoplasm 
(Moroianu et al.,  1995b; Grrlich et al.,  1995b). This indi- 
cates that the two subunits dissociate at this point. When, 
or how, the small subunit dissociates from the NLS is not 
yet known. 
A  third soluble factor, required only for the transloca- 
tion step  in  vitro, is  the  GTP-binding protein Ran/TC4 
(Moore and Blobel, 1993; Melchior et al., 1993).  Ran is a 
mainly nuclear protein in which the domains important for 
guanine nucleotide binding and GTP hydrolysis are con- 
served with respect to Ras and other small GTPases (Dri- 
vas et al., 1990). Experiments using nonhydrolyzable GTP 
analogues in the in vitro import system, or overexpression 
of a mutant version of yeast Ran that is stabilized in the 
GTP-bound form, indicate that hydrolysis of GTP by Ran 
is  a  prerequisite for nuclear import (Moore and Blobel, 
1993; Melchior et al.,  1993; Schlenstedt et al., 1995).  The 
guanine nucleotide exchange factor for Ran is RCC1 (Bis- 
choff et al., 1991a,b; for review see Dasso, 1993) while the 
Ran specific GTPase-activating protein is homologous to a 
previously known  yeast protein,  Rnalp  (Bischoff et al., 
1994, 1995). Both RCC1 and Rnalp are required for RNA 
export from the nucleus although, interestingly, RCC1  is 
mainly found in the nucleus and Rnalp in the cytoplasm, 
indicating that Ran would have to cross the nuclear enve- 
lope to interact with both proteins (for review see Izaur- 
ralde  and  Mattaj,  1995).  There  is  disagreement  as  to 
whether RCC1 is required for protein import in to the nu- 
cleus (Kadowaki et al., 1993; Tachibana et al.,  1994), but 
recently it has been shown that Rnalp is required for nu- 
clear import in yeast (Corbett et al., 1995). 
A fourth soluble factor has been shown to be required in 
vitro to give rates of nuclear import equal to those seen 
with unfractionated cytosol. It is a small, previously identi- 
fied protein initially called ppl5, but also known as pl0 or 
NTF 2  (Moore  and  Blobel,  1994;  Paschal  and  Gerace, 
1995). This protein was identified in two ways, first as an 
activity that stimulated import when present in a partially 
purified import system (Moore and Blobel, 1994), and as a 
factor required for import that interacted with the mam- 
malian  nuclear  pore  protein  p62  (Paschal  and  Gerace, 
1995).  pp15, like Ran, is only required for the transloca- 
tion step. 
In contrast to protein import, the mechanism of nuclear 
import of the spliceosomal snRNPs, U1, U2, U4, and U5 
has been much less well characterized. Kinetic competi- 
tion experiments in vivo have shown that at least some of 
the factors required for their nuclear import are distinct 
from those needed for protein import (Fischer et al., 1991, 
1993; Michaud and Goldfarb, 1991, 1992). This is explica- 
ble in terms of the distinct nature of the NLSs in these par- 
ticles. An essential, and apparently ubiquitously required 
signal, is formed when the snRNA is bound in the cyto- 
plasm  by a  group  of common  or core snRNP  proteins 
(Mattaj  and DeRobertis, 1985; Fischer et al., 1993).  The 
nature of the signal formed by snRNP core assembly is not 
defined, but it is distinct from karyophilic protein NLSs 
(Fischer et al.,  1991, 1993; Michaud and Goldfarb, 1991). 
In addition, the trimethyl guanosine cap structure (3mG) 
of these RNAs, formed in the cytoplasm by hypermethyla- 
tion of the monomethyl guanosine cap, is also part of their 
bipartite NLS (Fischer and Luhrmann, 1990; Hamm et al., 
1990).  In some cell types and for some snRNPs the 3mG 
cap is also essential for import, while in others it provides a 
less important accessory function to stimulate the rate of 
import (Fischer et al., 1991, 1993). An in vitro system simi- 
lar to that used in the study of nuclear protein import has 
recently been applied to the  study of U  snRNP  import 
(Marshallsay et al., 1994). Many of the in vivo characteris- 
tics of the snRNP import process were reproduced in this 
in vitro system, including the cell type specificity of 3mG 
cap dependence for import, which was shown to be con- 
ferred by the source of the cytosolic fraction used in the 
import experiments (Marshallsay et al., 1994). 
All these data are consistent with the hypothesis that 
snRNP import relies on a qualitatively distinct NLS recep- 
tor  from  that  used  in  protein  import.  To  determine 
whether these differences extend to a difference in a re- 
quirement for a  functional Ran GTPase cycle, we made 
use of dominant negative mutants modeled on equivalent 
mutations made in Ras (Der et al., 1986; Feig and Cooper, 
1988; Klebe et al., 1995). The results of these experiments, 
and  others using  nonhydrolyzable GTP analogues,  indi- 
cate that Ran is required for nuclear snRNP import. There 
are,  however,  quantitative  differences in  the  inhibition 
pattern  of protein  vs snRNP  import in  the presence of 
nonhydrolyzable GTP analogues which may indicate that 
the role of GTPases in the two processes is not identical. 
Materials and Methods 
Preparation of  KaryophUes 
The use of bacteriophage T'/RNA polymerase and T7 polymerase with 
the SV40 NLS in nuclear targeting has been described previously (Dunn 
et al., 1988).  The proteins were expressed in E.  coli  and purified as de- 
scribed (Davanloo et al., 1984).  Rabbit antisera specific for T7 RNA poly- 
merase was a generous gift from P. Fisher (SUNY Stony Brook). Fluores- 
cently labeled histidine tagged Xenopus nucleoplasmin was prepared as 
described (Grrlich et al., 1994a). 
BSA (Sigma) was labeled  with fluoroscein isothiocyanate (FLUOS, 
Boehringer Mannheim, Indianapolis, IN) and cross-linked to 50-fold mo- 
lar excess of a synthetic peptide (CGGGPKKKRKVED) containing the 
SV40 large T  antigen NLS (Melchior et al., 1993).  15-20 NLS peptides 
were cross-linked to each BSA molecule. A control karyophile was made 
in the same way using the reverse NLS peptide sequence. 
U snRNPs 
U snRNPs were isolated from HeLa nuclear extracts in a one step purifi- 
cation process as described by Bach et al. (1990). The anti~3mG antibody 
was commercial (Oncogene Science, Uniondale, NY). The isolated U sn- 
RNPs were modified by 100-fold excess of FLUOS (Boehringer Mann- 
helm) using the manufacturer's instructions. The labeled U snRNPs were 
repurified by 3mG affinity chromatography, but eluted in transport buffer 
(20 mM Hepes/KOH, pH 7.3,  110 mM potassium acetate, 5 mM sodium 
acetate, 2  mM magnesium acetate,  1 mM EGTA, 2  mM DTT,  1  mM 
PMSF, and aprotinin, leupeptin, and pepstatin A, 1 p.g/ml each), snRNP 
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clear extracts or purified fractions by phenol-chloroform extraction and 
ethanol precipitated, separated on an 8% denaturing gel and visualized by 
staining with ethidium bromide. The corresponding proteins were precipi- 
tated by acetone treatment, separated on a 20% SDS-polyacrylamide gel, 
and silver stained. 
Nuclear Import Assay 
The in vitro transport reactions (50 ILl) all contain 2 mM ATP, 2 mM cre- 
atine phosphate (Sigma Chem. Co., St. Louis, MO) and 1 U per ml creat- 
ine phosphokinase (Sigma Chem. Co.), 14 p~l Xenopus egg extract (New- 
meyer et al., 1986), and 104 digitonin-permeabilized HeLa cells (Adam et 
al., 1990). T7-NLS, BSA-NLS, nucleoplasmin, or U snRNPs were used as 
karyophiles. (Final concentrations ,~20 p,g/ml, 60/~g/ml, 10 p,g/ml, and 20 
p,g/ml, respectively.) Nonhydrolyzable GTP analogues and mutant Ran 
protein additions were made to the basic import reaction plus karyophile. 
Fluorescent dextrans were obtained from Sigma Chem. Co. 
Incubations were carried out at 25°C and samples were taken at various 
times, diluted rapidly with transport buffer (Adam et al., 1990)  and fixed 
with paraformaldehyde on ice. The fixed reaction was layered over 30% 
sucrose in transport buffer in a tube containing a polylysine-coated cover- 
slip. After centrifugation (1,000 g for 10 rain) the coverslip was recovered. 
When  fluorescently  labeled  substrates  were  used,  the  coverslip  was 
washed in PBS containing DAPI dye (330 ng/ml) and mounted on top of a 
drop of Vectashield mounting medium (Vector Laboratories, Burlingame, 
CA) and viewed directly. Unlabeled substrates were detected by indirect 
immunofluorescence using specific rabbit antisera and fluorescent second 
antibodies.  ATP-depleted conditions were  obtained omitting ATP and 
the ATP-regenerating system and by preincubation with hexokinase and 
glucose (Newmeyer et al., 1986). 
Quantitative Fluorescence Microscopy 
Quantitation of nuclear fluorescence was performed on a ZEISS inverted 
fluorescence ~Jght microscope (Axiovert 10) equipped with a cooled CCD 
camera (Photometrics CH250, 1317 x  1035 pixels). Image acquisition was 
completely controlled  from  a  Sun  Microsystems workstation  (SPARC 
Station 10/41) with the software package KHOROS. Two separate images 
were taken for each field of cells on a coverslip, one image of the DAPI 
staining of cell nuclei and one image of the fluorescein of the stained cells. 
The area of the cell nuclei was then localized and determined by adjusting 
an  appropriate  threshold.  Image pixels with intensities lower than the 
threshold were considered as background and those above the threshold 
as cell nuclei. On this image an automatic labeling procedure was applied 
that counted the found objects, numbered them, calculated the area, and 
discarded  those below a  certain size limit to exclude small fluorescent 
spots in the image. The setting of the threshold was controlled by overlay- 
ing the labeling image with the fluorescein image and comparison of ceil 
nuclei areas in both images. Mean intensities of cell nuclei was then calcu- 
lated by integrating the pixel intensities of the fluorescein image in the re- 
gions of the labeled objects divided by the object area. For fluorescence 
microscopy, samples were visualized using 63×  or 100× objectives on a 
Zeiss Axiophot microscope equipped with epifiuorescence. Photographs 
were taken on T max 400 film (Kodak). For confocal fluorescence micros- 
copy,  the modular confocal microscope, developed  and constructed at 
EMBL, was used. Excitation wavelengths of 488 nm were selected from 
an Argon-ion laser (Carmo-Fonseca et al., 1991).  Images were analyzed 
by Adobe Photoshop version 3.0. 
GTPase Activity Assay 
Wild-type RanFFCA and the Q69L mutant proteins were incubated for 60 min 
at 25°C with a  10-fold excess of [7-32p]GTP (specific activity 480 cpm/ 
pmol) in 30 mM potassium phosphate, pH 7.4, 2 mM EDTA, 5 mM DTE, 
and 50 mM KCI. After the removal of the noncomplexed [~t-32P]GTP, the 
concentration of the complexed protein was determined by filtering dupli- 
cate aliquots through nitrocellulose membranes and measuring the mem- 
brane bound radioactivity by liquid scintillation counting. 320 Ixl of 1 IxM 
Ran- or RanQ69L-[-y-32p]GTP complex were then mixed with 4 ILl of Xe- 
nopus egg extract (30 mg/ml protein). 32p release was determined by dilut- 
ing 30-1tl  aliquots of the reaction mixture in  1 ml charcoal suspension 
(Leupold et al.,  1983). The mixture was vortexed for 15 s, centrifuged, and 
700 pJ of the supernatant was counted by liquid scintillation counting. 
Ran Mutants 
Mammalian Ran and the mutant Ran proteins were expressed in E. coti as 
untagged proteins and purified as described (Bischoff et al., 1994).  The 
molecular weights of the purified proteins were checked by mass spec- 
trometry. 
GTP and Cap Analogues 
The cap analogues were synthesized as described (Darzynkiewicz et at., 
1985; Carberry et al., 1990) and provided by E. Darzynkiewicz. Nonhydro- 
lyzable GTP analogues were from Boehringer Mannheim. 
Results 
snRNP Import is Inhibited by Cap Analogues In Vitro 
U  snRNPs were purified using immuno-affinity chroma- 
tography with an antibody specific for the trimethyl gua- 
nosine cap of the U snRNA and then fluorescently labeled 
(Materials and  Methods). To circumvent possible prob- 
lems arising from dissociation of proteins during fluores- 
cent labeling, the labeled snRNPs were repurified by cap 
affinity  chromatography before use. The RNA and protein 
composition of the U  snRNP fractions at each stage in 
their preparation is shown in Fig. 1, a and b. The in vitro 
system used throughout this paper  combines the use of 
digitonin-permeabilized mammalian cells  (Adam  et  al., 
1990)  and cytosol fractions derived from Xenopus eggs 
(Newmeyer et al., 1986). 
In this in vitro system fluorescently labeled U  snRNPs 
accumulate in the nuclei of permeabilized cells (Fig. 1 c). 
Consistent with previous reports (Marshallsay et al., 1994), 
we find that the rate of protein import is more rapid than 
snRNP import, maximum protein accumulation is observed 
within an hour, while maximal snRNP accumulation takes 
between 1 and 2 h (data not shown), snRNP import is effi- 
ciently blocked by the tri-methyl guanosine cap analogue, 
m2,2,7GTP (Fig. 1 d), but is not significantly affected by the 
mono-methyl guanosine cap analogue mTGTP (Fig. 1 e). 
Quantitation of the levels of snRNP and Xenopus nucleo- 
plasmin accumulation in the presence of 2 mM m2,Z7GTP 
show that snRNP import is reduced to approximately one 
third of control levels in a 2-h incubation while nucleoplas- 
rain accumulation is not significantly affected (Table  I). 
Lower concentrations of m 2,2,7 GTP had proportionately 
lower inhibitory effects (data not shown) but higher con- 
centrations (up to 10 mM) did not lead to greater inhibi- 
tion of snRNP or protein accumulation. 
The  specific inhibition of snRNP import by cap  ana- 
logues argues against the observed accumulation being due 
to protein that has dissociated from the labeled U snRNPs 
during the  import reaction.  In addition the common or 
core U snRNP proteins, which represent the bulk of the la- 
beled proteins in our preparations (Fig. 1 b) do not enter 
the nucleus unless bound to RNA (Mattaj and De Rober- 
tis,  1985), and have been shown not to exchange at a de- 
tectable rate between different snRNPs in vivo (Fischer et 
al., 1993). The other class of U snRNP proteins, those spe- 
cific for a particular snRNP, are a not major fraction of the 
labeled protein  in most of our preparations  and cannot 
contribute significantly to the observed accumulation; those 
U  snRNP-specific proteins that were studied have a con- 
ventional protein NLS and their uptake would not be in- 
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of Nucleoplasmin  and U snRNPs in the Absence or Presence 
of Cap Analogues 
Control  m2.2.7GTP  7mGTP 
2 mM 
Nucleoplasmin  100 -  9.90  86 +-_ 5.50  100 ___ 9.0 
snRNPs  100 -+ 7.24  29 _+ 4.90  86 +  9.80 
"fhe nuclear uptake of nucleoplasmin  and U snRNPs after 120 rain incubation  in the 
absence (control)  or presence of m2'Z'7GTP  and m7GTP cap analogues (both 2 raM) 
was quantified.  The value  obtained  in the transport  reaction  for both karyophiles  in the 
absence  of any cap analogue  (control)  was taken  as 100% import.  The values  obtained 
in the import  reactions  in the presence  of m2'2'TGTP  and mTGTP  cap analogues  (both 2 
raM) are relative  to the control.  The table shows the average  figures  for more than 50 
cells per experiment  in two independent  experiments.  The errors are standard  devia- 
tions. The transport  reactions were as described in Materials  and Methods. Fluores- 
cently labeled  nucteoplasmin  and affinity-purified  fluorescently  labeled  snRNPs  were 
used as karyophiles. 
Figure 1.  In vitro import of U  snRNPs is specifically inhibited by 
the 3mG cap analogue m 2,2'7 GTP. (a) Analysis of RNA from la- 
beled snRNPs. RNAs were analyzed by denaturing electrophore- 
sis. Total RNA from HeLa nuclear extract (left lane), U  snRNPs 
purified on a 3mGcap antibody column (center lane), and fluores- 
cently labeled U  snRNPs repurified on the same column (right 
lane). (b)  Analysis of proteins  from  labeled  snRNPs.  Proteins 
were separated on high percentage polyacrylamide gels to resolve 
the small E, F, and G  proteins. Total protein from HeLa nuclear 
extract (lane 1), U  snRNP proteins extracted after a single round 
of purification on a 3rag cap antibody column (lane 2). The same 
proteins on a lower percentage gel (lane 3). High percentage gel 
analysis of proteins from fluorescently labeled U  snRNPs repuri- 
fled on the cap affinity column visualized by silver stain (lane 4) 
or by fluorescence (lane 5). The most intensely labeled bands cor- 
respond to the A and D proteins. (c-d) In vitro import of U snRNPs. 
Digitonin-permeabilized HeLa cells were incubated with affinity- 
purified fluorescently labeled U  snRNPs for 120 rain in the pres- 
ence of Xenopus egg extract, ATP and an ATP regeneration system 
(see  Materials  and  Methods),  The  transport reaction was  per- 
formed in the absence (c) or presence of mz'2"7GTP (d) or mTGTP 
(e) cap analogues both at 2 mM final concentration. 
nal concentrations between 1 and 5 mM. However, quanti- 
tatively, GMPPNP is the most potent inhibitor, reducing 
the level of accumulation by a  factor of fifty (Table II). 
GMPPCP was the least effective inhibitor, a concentration 
of 1 mM causing an approximately fourfold reduction in 
accumulation (Table II). The same analogues also inhib- 
ited snRNP nuclear accumulation in vitro (Table II, Fig. 2, 
lower panels).  A  comparison of the quantitative effects of 
the analogues on snRNP and protein import (Table II) in- 
dicates that snRNP is less sensitive than protein import, an 
hibited by cap analogues. We conclude that specific U snRNP 
import is being observed and that the in vitro system faith- 
fully reproduces  crucial aspects  of U  snRNP  import, in 
agreement  with the  previous  data of Marshallsay et  al. 
(1994). 
Nonhydrolyzable GTP Analogues Inhibit Both 
Protein and snRNP Import 
Studies of the role of GTPases in cellular processes has re- 
lied extensively on the use of nonhydrolyzable GTP ana- 
logues and their use in studies of protein import led to the 
identification and characterization of Ran as the essential 
factor for the translocation step of nuclear protein import 
(Melchior et al., 1993; Moore and Blobel, 1993). 
The  analogues  GTP~/S,  GDP[~S,  GMPPNP  (guanylyl 
imidodiphosphate),  and  GMPPCP  (guanylyl  methylene- 
diphosphonate) all inhibited nuclear protein accumulation 
in vitro  (Table II, Fig.  2, upper panels).  The maximal  in- 
hibitory effect of all of these analogues was observed at fi- 
Figure 2.  Inhibition of BSA-NLS conjugate or U  snRNP import 
in  vitro  by  the  nonhydrolyzable  GTP  analogues,  GTP~,S,  and 
GMPPNP.  (Upper)  In vitro nuclear uptake  of fluorescently la- 
beled BSA-NLS  after  120  min  incubation  (a).  The  nonhydro- 
lyzable GTP analogues GTP~,S and GMPPNP were added to the 
transport reaction at 1 mM final concentration (b and c, respec- 
tively). (Lower) In vitro nuclear uptake of purified fluorescently 
labeled U  snRNPs in the absence (a) or presence of GTP~/S and 
GMPPNP  at  1  mM final concentration (b  and c,  respectively). 
Nuclei were photographed under identical conditions, leading to 
overexposure of the control nuclei in upper panel a. 
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Control  GTP-~/S  GDP[3S  GMPPNP  GMPPCP 
1 mM 
BSA-NLS  100 ±  0.7  11  +  6.8  22 ±  10  2.0 ±  1.0  22 -+  11 
snRNPs  100 ±  14  34.5 ±  4.0  37 _+  1. l  28.5 -  3.5  30 ±- 5.0 
The import of BSA-NLS conjugate and U snRNPs after 120 min in the absence (control) or presence of different nonhydrolyzable  GTP analogues was quantified. The nonhydro- 
lyzable GTP analogues  were GTP',/S, GDP[3S, GMPPNP, and GMPPCP. The background  nuclear fluorescence measured in the absence of ATP has been subtracted from the fig- 
ures. The table shows the average values of more than 50 cells each from at least two different experiments.  The errors are standard deviations. 
approximately threefold reduction occuring with all three 
analogues. 
An  additional,  possibly significant  difference  between 
snRNP import and protein import is the apparent absence 
of docking of snRNPs at the nuclear envelope under con- 
ditions where nuclear proteins can be detected bound to 
the nuclear envelope. Thus, when snRNP import was as- 
sayed in the absence of ATP no accumulation at the enve- 
lope was observed (data not shown).  We have observed 
some nuclear envelope binding of nuclear proteins in the 
presence of GTP~S and GMPPNP with a small amount of 
intranuclear fluorescence (Fig. 2, upper panels a-c), how- 
ever, the effect of GTP~/S was variable, causing only very 
weak perinuclear accumulation in some experiments. Con- 
sistent  with  previously published  data  weak  perinuclear 
accumulation could be detected in the presence of GDPI3S 
but  was  always less  than  that  seen under  conditions  of 
ATP depletion (data not shown, Moore and Blobel, 1993). 
In  contrast,  when  U  snRNP  import  was  assayed,  these 
three  analogues  (GTP-/S, GMPPNP,  and  GDPI3S) were 
inhibitory but none caused  a  detectable accumulation of 
snRNPs at the nuclear envelope (Fig. 2, lower panels a-c). 
Mutant Ran Proteins Inhibit Both Protein 
and U snRNP Import 
The results of the experiments with nonhydrolysable GTP 
analogues suggested that at least one GTPase is involved 
in snRNP nuclear import. Ran is the only nuclear GTPase 
known  to be essential  for nuclear  protein  import and  a 
mutant Ran protein expressed in yeast acts as a dominant 
negative  inhibitor  simultaneously  inhibiting  protein  im- 
port and RNA export (Schlenstedt et al., 1995).  We have 
used two mutant Ran proteins to investigate the role of 
Ran in protein and snRNP import. In one glutamine 69 is 
changed to leucine  (Q69L). This protein is insensitive to 
Ran GTPase-activating protein (Ran GAP) and persists in 
the GTP bound state and is functionally equivalent to the 
mutant used by Schlenstedt et al. (1995); (Bischoff et al., 
1995). To ensure that the Q69L mutant protein exhibited 
the same properties in the conditions of the nuclear trans- 
port assay, its GTPase activity was compared with that of 
wild-type Ran in the presence of Xenopus egg extract. The 
GTPase activity of the two proteins in a phosphate release 
assay (Leupold et al.,  1983)  in the presence of Xenopus 
egg extract is shown in Fig. 3. The wild-type protein hydro- 
lyzed GTP rapidly at rates comparable to those measured 
in other systems (Klebe et al., 1995)  while the Q69L mu- 
tant exhibited only weak activity. 
Direct addition of Q69L mutant protein to the in vitro 
transport reaction completely inhibited the import of nu- 
cleoplasmin and a T7 RNA polymerase fusion protein hav- 
ing a single copy of the SV40 T antigen NLS (Fig. 4, a--d). A 
titration to determine the concentration of mutant protein 
required  to inhibit nuclear protein import indicated that 
the import of both the T7 RNA polymerase-NLS fusion 
and of nucleoplasmin were progressively inhibited up to a 
concentration of 2 ~M. Additional increases in concentra- 
tion caused no significant increase in inhibition (data not 
shown). The concentration of Ran in the egg extracts used 
in these experiments was determined by quantitative im- 
munoblotting  and  found  to be 2-3  IxM,  consistent  with 
previously reported estimates for oocyte extracts (Moore 
and Blobel, 1993). This gives a final concentration of Ran 
in the assay of ~0.5-1 IxM indicating that the inhibitory ef- 
fect of Q69L occurs in the presence of approximately stoi- 
chiometric amounts of endogenous wild-type protein. 
The import of fiuorescently labeled purified U  snRNPs 
in the presence of 2, 5, and 10 p,M Q69L was then investi- 
gated and compared to the uptake of the BSA-SV40 NLS 
conjugate under identical conditions. For both karyophiles 
the addition of 2 IxM Q69L caused a drastic inhibition of 
import which was unchanged by further addition  of mu- 
tant protein (Figs. 5 and 6, a-d, Table III). As a control the 
addition of the wild-type Ran protein had only a small ef- 
fect on either protein or snRNP import even at a  maxi- 
mum concentration of 10 txM (Figs. 5 and 6, panel e, Table 
III). As further controls for the specificity of the inhibitory 
0.8- 
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Figure 3.  Stimulation of the GTPase activity of purified recombi- 
nant Ran and RanQ69L proteins by Xenopus egg extracts. The 
GTPase activities of recombinant Ran and RanQ69L are mea- 
sured by a phosphate release assay in which [~/-3ZP]GTP  bound 
forms of the proteins were incubated with Xenopus egg extract 
and the release of 32pi was plotted versus time. The phosphate re- 
lease by wild-type Ran/TC4 protein (circles) and RanQ69L pro- 
tein (triangles) is shown.  (RanQ69L is a mutant of Ran/TC4 in 
which glutamine 69 has been changed to leucine.) 
Palacios et al. Ran in Protein and snRNP Nuclear Import  489 Figure 4.  Inhibition  of nuclear uptake of T7-NLS fusion protein 
and nucleoplasmin  by the addition  of RanQ69L protein. The im- 
port of  T7-NLS fusion protein (a and b) and nucleoplasmin (c and d) 
was assayed in the absence (a and c) or presence of 10 p~M puri- 
fied recombinant RanQ69L protein (b and d) after 60 rain incu- 
bation. The transport reactions were as described in Fig. 1. Nucle- 
oplasmin was fiuorescently  labeled while T7-NLS fusion protein 
was detected by immunofluorescence. 
effect of the  Q69L mutant, equivalent versions of either 
Ras (Q61L Der et al., 1986) or Rab5 (Q79L Stenmark et 
al., 1994) were added to the in vitro system and we found 
that neither protein had any detectable effect on nuclear 
protein import (data not shown). 
In  the  other  mutant  protein  (T24N)  threonine  24  is 
changed to asparagine. This protein binds GTP poorly but 
has wild-type GTPase activity in the presence of the Ran 
GAP  and  thus  accumulates  in  the  GDP-bound  form 
(Klebe et al., 1995).  When added to nuclear reconstitution 
experiments  in  Xenopus  egg  extracts  this  protein  sup- 
presses nuclear growth and prevents DNA replication and 
has a slight effect on nuclear protein import which was not 
quantitated  (Kornbluth et al., 1994).  We have found that 
this  protein  also  inhibits  the  accumulation  of the  BSA- 
SV40 NLS conjugate and snRNPs (Figs. 7 and 8 and Table 
IV).  Quantitatively the  effects are  significantly less pro- 
nounced than those observed with Q69L, the level of inhi- 
bition increasing as the concentration of mutant Ran pro- 
tein is increased to 10 p,m (compare Tables III and IV). In 
the presence of Q69L, no clear nuclear envelope staining 
is observed (Figs. 4  and 5). In the presence of T24N, the 
small amount of protein which does enter the nucleus is 
preferentially associated with the nucleoli (Fig. 7). 
The inhibitory effects of Q69L and T24N mutant Ran 
proteins differ in the extent to which the inhibition can be 
relieved by the subsequent  addition of wild-type protein. 
The inhibition of both nuclear protein and snRNP import 
brought about by the presence of 2  IxM Q69LRan could 
not  be  reversed  by  10  p,M  wild-type  protein,  and  only 
weak restoration was observed using 20 p,M wild-type pro- 
tein in the presence of 200 p.M GTP (data not shown). By 
contrast the inhibition  of protein and snRNP import ob- 
served in the presence of 2  p,M  T24N  Ran could be re- 
stored by the addition of 2 I~M wild-type protein (data not 
shown). 
The inhibition of U  snRNP import by the mutant Ran 
proteins could be indirect, being due to either blockage of 
nuclear pores by improperly imported nuclear substrates 
derived from the added cytosol, or to an effect on the im- 
port of a hypothetical protein factor whose uptake would 
be required  for U  snRNP import to occur. To show that 
there is not a  generalized blockage of the nuclear pores, 
we studied the entry of a  small (4.4 kD) fluorescently la- 
beled dextran. The nuclear entry of this dextran was unaf- 
fected by the addition of either wild-type Ran or the T24N 
or Q69L mutant proteins (Fig. 9, a-d). The integrity of the 
Figure 5.  The in vitro import of a fluo- 
rescently  labeled BSA-NLS  conjugate 
is  inhibited  by  the  addition  of 
RanQ69L protein.  In vitro nuclear up- 
take of fluorescently labeled BSA-NLS 
conjugate  was  performed  in  the  ab- 
sence  (a) or presence of 2 p.M, 5 IxM, 
and  10  I~M  purified  recombinant 
RanQ69L protein (b, c, and d, respec- 
tively),  e  shows  the  import  of BSA- 
NLS conjugate when purified recombi- 
nant wild-type Ran protein was added 
to the reaction to a final concentration 
of 10 p.M. 
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inhibited  by the addition  of RanQ69L pro- 
tein. In vitro nuclear uptake of affinity-puri- 
fied fluorescently labeled U snRNPs was as- 
sayed after 120 min incubation in the absence 
(a) or presence of 2 IxM, 5 IxM, and 10 p,M 
purified recombinant  RanQ69L protein (b, c, 
and d, respectively). In e, purified  recombi- 
nant wild-type Ran protein was added to the 
reaction to a final concentration of 10 p~M. 
nuclei used in this experiment was demonstrated by the 
exclusion of a larger dextran (Fig. 9 e). To address the possi- 
bility that snRNP import could be dependent upon the im- 
port of a nuclear protein, we added an excess of the BSA- 
NLS peptide synthetic karyophile such that the uptake of 
nucleoplasmin  was  efficiently competed  (Table  V).  The 
same  concentration of the  BSA-reverse NLS  conjugate 
was  not  inhibitory.  Under  these  conditions,  where  a 
greater than tenfold reduction of nucleoplasmin uptake oc- 
curred, U snRNPs were still efficiently  imported (Table V). 
Discussion 
Docking of snRNPs at the Nuclear Envelope 
Cannot be Detected 
Previous studies  of the nuclear import of proteins and 
snRNPs  have emphasized the differences between these 
two classes of karyophile. Competition experiments have 
shown that these karyophiles are accumulated in the nu- 
cleus  by biochemicaUy distinct  pathways  (Michaud  and 
Goldfarb, 1991; Fischer et al., 1991, 1993).  A further indi- 
cation of the distinct nature of the early steps of the import 
of proteins and snRNPs is the apparent lack of docking at 
the nuclear envelope when U snRNPs were used as a sub- 
strate for import. Docking of nuclear proteins occurs most 
prominently when high energy phosphate (ATP) is lacking 
(Newmeyer et al., 1986; Richardson et al., 1988), or in the 
absence of Ran  (Moore and Blobel, 1993). Docking can 
also be observed at a low level in the presence of the GDP 
analogue GDPI3S (Moore and Blobel, 1993;  this paper). 
We find no detectable accumulation of U  snRNPs at the 
nuclear envelope under conditions where nuclear protein 
docking is observed. It is possible that docking of snRNPs 
at the NPC does occur but it is either too transient or oc- 
curs at too low a level to be detected. 
Nonhydrolyzable GTP Analogues Inhibit Both Protein 
and snRNP Import 
The addition of nonhydrolyzable GTP analogues to the in 
vitro import assay inhibited both nuclear protein and sn- 
RNP import.  Quantitatively, however, the  analogues  all 
had a detectably greater effect on protein import than sn- 
RNP import.  One possible explanation is  that given the 
slower rate of snRNP import, the contribution of GTPase 
activities  is  less  than  the  case  of nuclear  proteins,  i.e., 
fewer cycles of GTP hydrolysis and nucleotide exchange 
are  required  per mole  of substrate.  Alternatively, addi- 
tional  GTPases  specific for each karyophile and  having 
different sensitivities to the analogues may be involved. 
Our results with nuclear proteins differ from published 
results because we observe docking in the presence of GTI~S 
and GMPPNP. In this respect the effects of GTP-yS were 
variable and may be explained by the observation that the 
ratio of the number of permeabilized cells to the concen- 
tration of extract determines whether nuclear protein im- 
port can be inhibited by GTP~/S (Melchior et al.,  1993). 
For comparative purposes we used a fixed ratio of nuclei 
Table III. Quantitation of the Nuclear Uptake of BSA-NLS Conjugate and U snRNPs In Vitro in the Absence or Presence of 
Different RanQ69L Mutant Proteins 
Ran 
Control  Q69L  wt 
2 pM  lO laM  IO laM 
BSA-NLS  100 ±  0,97  0.72 +- 0.04  0.64 -+- 0.03  61  -  1.18 
snRNPs  100 ±  10.9  12 _  1.34  13  -  1.84  65 +  3.16 
Quantitation  of the import of BSA-NLS conjugate  and U snRNPs after 120 rain in the absence (control) or presence of RanQ69L (2 and 10 mM) and wild-type  Ran (10 mM) is 
shown. Both the BSA-NLS conjugate and the purified U snRNPs were fluorescently  labeled. The value obtained in the transport reaction for both karyophiles in the absence of any 
added Ran protein (control) was taken as 100% import. The values obtained in the import reactions in the presence of RanQ69L and wild-type Ran proteins are relative to the con- 
trol. The table shows the average figures for more than 50 cells per experiment.  The errors are standard deviations. 
Palacios et al. Ran in Protein and snRNP Nuclear Import  491 Figure 7.  The in vitro import of a fluorescently labeled BSA-NLS 
conjugate  is inhibited  by the addition  of RanT24N protein.  In 
vitro nuclear uptake of fluorescently labeled BSA-NLS conjugate 
was performed in the absence (a) or presence of 2 wM, 5 I~M,  and 
10 wM purified  recombinant RanT24N protein (b, c, and d, re- 
spectively). 
Figure 8.  The import of U snRNPs in vitro is inhibited by the ad- 
dition  of RanT24N protein. In vitro nuclear uptake of affinity- 
purified  fluorescently  labeled U snRNPs was assayed after 120 
min incubation in the absence (a) or presence of 2 t~M, 5 I~M,  and 
10 ~M purified  recombinant RanT24N protein (b, c, and d, re- 
spectively). 
and extract as we found that dilution of the egg extract sig- 
nificantly reduced snRNP import (data not shown). 
Mutant Ran Proteins Inhibit Both Protein 
and snRNP Import 
The dominant negative inhibition of both protein and sn- 
RNP import by two different mutant Ran proteins impli- 
cates Ran/TC4 as a common factor in the import of both 
karyophiles, contrasting with the  clear differences in the 
cytosolic and possibly nuclear pore complex components 
responsible  for their import.  Interestingly, there  are de- 
tectable differences in the affects of the two mutant Ran 
proteins. Q69L has a quantitatively larger inhibitory affect 
on protein import while T24N affects protein and snRNP 
import almost equally. The Q69L Ran mutant protein that 
is insensitive to GAP activity is quantitatively and qualita- 
tively the  most  potent  and  least  reversible  inhibitor  of 
both protein and snRNP import. 
While the direct role of Ran/TC4 in nuclear protein im- 
port has been unequivocally demonstrated, our results us- 
ing mutant Ran proteins to implicate Ran in snRNP im- 
port could be explained as a secondary consequence of the 
inhibition of protein import or blocking of the pore. We 
have  eliminated  these  possible  explanations  by showing 
that pores are not blocked; for example, by the presence of 
improperly imported substrates from the cytosol because 
they remain permeable to dextran.  U  snRNP import ap- 
pears not to be dependent upon nuclear protein import as, 
inhibition of nuclear protein uptake with an excess of syn- 
thetic karyophile does not significantly inhibit U  snRNP 
Table IV. Quantitation  of the Nuclear Uptake of BSA-NLS 
Conjugate and U snRNPs In Vitro in the Absence or Presence 
of RanT24N Mutant Protein 
Control  RanT24N 
2 p2vI  5lzM  10 txM 
BSA-NLS  100 +  3.8  55 +  6.0  29 +-- 7.5  19 ±  3.8 
snRNPs  100 ±  11.8  38 -  3.7  25  +  3.1  24 ±  9.4 
Quantitation of the import of BSA-NLS conjugate and U snP.NPs after 120 min in the 
absence (control) or presence of RanT24N (2, 5, and 10 tzM). Both the BSA-NLS con- 
jugate and the purified  U snRNPs  were fluorescently  labeled. The value obtained  in 
the transport  reaction  for both karyophiles  in the absence  of any added Ran protein 
(control) was taken as 100% import, The values obtained in the import reactions in the 
presence of RanT24N proteins are relative to the control. The table shows the average 
figures for more than 50 cells per experiment. The errors are standard deviations. 
Figure 9.  Diffusion of a fluorescently labeled dextran into the nu- 
cleus is not blocked by Ran mutant proteins.  In vitro nuclear en- 
try of a 4.4-kD fluorescently labeled dextran (a) in the absence of 
added Ran protein;  (b) in the presence of 2 ~M wild-type Ran; 
(c) 2 p.M Q69L Ran; and (d) 2 p~M T24N Ran. (e) Exclusion of a 
145-kD fluorescently  labeled  dextran in  the absence  of added 
Ran protein. 
The Journal of Cell Biology, Volume 133,  1996  492 Table V. Competitive Inhibition of Nuclear Protein Import 
Does Not Inhibit U snRNP Import In Vitro 
Control  BSA-NLS  BSA-NLSRev 
O. 35 mg/ml 
Nucleoplasmin  100 _.+ 2.80  8 +  1.60  112 __+  11.40 
snRNPs  100 --_ 2.50  66 _+ 3.40  93  _  3.00 
Quantitation of the import of fluomscently labeled nucleoplasmin and fluorescenfly 
labeled U snRNPs in the presence of reverse BSA-NLS conjugate or the BSA-NLS 
conjugate in vitro after 120 min. The table shows  the average figures for more than 50 
cells in an experiment. The errors are standard deviations. 
import.  There  is  probably  a  single  pathway for  nuclear 
protein import (Michaud and Goldfarb, 1993), and the re- 
suits described here demonstrate that U  snRNP import is 
not dependent upon the operation of this pathway and is 
consistent with in vivo competition experiments  (Fischer 
et al., 1991; Michaud and Goldfarb, 1991) and experiments 
in which a cytoplasmically anchored nuclear protein spe- 
cifically interferes with nuclear protein import but not U1 
snRNA import (van Zee et al., 1993). All of these data are 
consistent with the existence of different classes of recep- 
tor that recognize protein or U  snRNP NLSs, but do not 
rule out that steps of import subsequent to NLS receptor 
binding  (i.e.,  docking  and/or  translocation  through  the 
NPC) might occur by a common mechanism. It is possible 
that the requirement for Ran for the import step of both 
karyophiles is indicative of such a common step. 
While our results establish Ran/TC4 as the first known 
factor required for the import of both nuclear proteins and 
U  snRNPs, the differences we observe in the sensitivity of 
import of the two classes of karyophile to nonhydrolyzable 
GTP analogues and mutant Ran proteins suggest that in 
addition to Ran, other GTPases may be involved. A  more 
direct biochemical approach to the identification of factors 
involved in snRNP import should clarify the basis of these 
differences. 
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